Industry News

Industry News

Lung Tumor Gene Test Predicts Surgery Outcomes

Jan 27, 2012

An assay which measures the activity of 14 genes in lung cancer tumors can accurately predict who will respond well to surgery and who will probably die within five years, researchers from the University of California, San Francisco, reported in The Lancet... Read More

Lung Tumor Gene Test Predicts Surgery Outcomes

Jan 27, 2012

An assay which measures the activity of 14 genes in lung cancer tumors can accurately predict who will respond well to surgery and who will probably die within five years, researchers from the University of California, San Francisco, reported in The Lancet... Read More

Brachytherapy Lowers Prostate Cancer Mortality

Jan 27, 2012

According to a study from radiation oncologists at the Kimmel Cancer Center at Jefferson, high-risk prostate cancer patients who receive brachytherapy, alone or together with external beam radiation therapy (EBRT) had considerably lower mortality rates. The study is published online January 23 in the International Journal of Radiation Oncology*Biology*Physics... Read More

Cancer Screening Rates Low Among Ethnic Groups, USA

Jan 27, 2012

Not only are relatively few Americans screened for cancer, but there are considerable disparities between ethnic and racial groups in the country, says a new report issued by NCI (National Cancer Institute) and the CDCF (Centers for Disease Control and Prevention). The authors added that screening rates are especially low among Hispanic and Asian Americans... Read More

Cancer Screening Rates Low Among Ethnic Groups, USA

Jan 27, 2012

Not only are relatively few Americans screened for cancer, but there are considerable disparities between ethnic and racial groups in the country, says a new report issued by NCI (National Cancer Institute) and the CDCF (Centers for Disease Control and Prevention). The authors added that screening rates are especially low among Hispanic and Asian Americans... Read More

Men At Greater Risk For Oral HPV Infection, HPV-Related Cancers

Jan 27, 2012

Oral HPV infection is more common among men than women, explaining why men are more prone than women to develop an HPV related head and neck cancer, according to a study presented at the Multidisciplinary Head and Neck Cancer Symposium, sponsored by AHNS, ASCO, ASTRO and SNM... Read More

IMRT Improves Head And Neck Cancer Patients' Long-Term Quality Of Life

Jan 27, 2012

Patients treated with IMRT for head and neck cancer report an increasingly better quality of life post-treatment when compared to patients receiving other forms of radiation therapy, according to a study presented at the Multidisciplinary Head and Neck Cancer Symposium, sponsored by AHNS, ASCO, ASTRO and SNM... Read More

Side Effect Severity Predicted In Head And Neck Cancer Patients By Thermal Imaging To Detect Oral Temperature Changes

Jan 27, 2012

Slight temperature increases of the oral mucus membranes early in a head and neck cancer patient's chemotherapy and radiation therapy (chemoradiotherapy) treatment is a predictor of severe mucositis later in treatment, according to a study presented at the Multidisciplinary Head and Neck Cancer Symposium, sponsored by AHNS, ASCO, ASTRO and SNM... Read More

Long-Term Positive Results From Radiation Plus Chemotherapy For Head And Neck Cancer Patients

Jan 27, 2012

A select subgroup of advanced head and neck cancer patients treated with radiation therapy plus the chemotherapy drug cisplatin had more positive outcomes than patients treated with radiation therapy alone and continued to show positive results 10 years post-treatment, according to a study presented at the Multidisciplinary Head and Neck Cancer Symposium, sponsored by AHNS, ASCO, ASTRO and SNM... Read More

Cancer Patients' Treatment, Diagnosis Wait Time Reduced By Danish Health Care Fast Track Program

Jan 27, 2012

In Denmark, implementing a national fast track system for cancer patients reduced the waiting time between a patient's initial meeting with a health care provider and their first treatment by four weeks when comparing 2010 to 2002, according to a study presented at the Multidisciplinary Head and Neck Cancer Symposium, sponsored by AHNS, ASCO, ASTRO and SNM... Read More

Previous Page   Next Page